Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs

Stroke - United States
doi 10.1161/01.str.0000126871.98801.6e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2014English

Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry

PLoS ONE
Multidisciplinary
2014English

Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke

Expert Opinion on Drug Delivery
Pharmaceutical Science
2017English

Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (R-Tpa) in Acute Ischemic Stroke

Jentashapir Journal of Health Research
2016English

Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.

Journal of Pharmacobio-Dynamics
1992English

Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2006English

Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke

The Egyptian Journal of Hospital Medicine
2018English

Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Changes in Coagulation and Fibrinolysis Markers in Acute Ischemic Stroke Treated With Recombinant Tissue Plasminogen Activator

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy